Access Clinical Trials Compliance Packaging 
Cannabis Law Report
NOVEMBER 19, 2021
It has been designated a Breakthrough Therapy by the FDA and the results of our pivotal Phase 3 clinical trial were published in Nature Medicine or profiled on the front page of The New York Times. MAPS PBC strives to establish a supportive, equitable and accessible work environment. European Regulatory Lead Executive Summary.
Cannabis Law Report
OCTOBER 2, 2021
The results of our successful pivotal Phase 3 clinical trial were recently published in Nature Medicine and profiled on the front page of The New York Times. MAPS PBC strives to establish a supportive, equitable, and accessible work environment. Competitive benefit package includes: Paid Time Off (PTO). Holiday Pay.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Cannabis Law Report
SEPTEMBER 8, 2021
Key Transaction Details: The Valens Company, a leading Canadian manufacturer of cannabis products, has entered into a long-term partnership with Epsilon, for exclusive access to the Epsilon’s GMP Manufacturing Facility in Southport , Queensland Australia (the “ Southport Facility ‘).
Cannabis Law Report
FEBRUARY 5, 2022
Responsible for creation and maintenance of all regulatory documentation, including but not limited to, product packaging, labelling, inserts, working in conjunction with the marketing team for design, and assuring regulatory compliance across all territories. ROLE/RESPONSIBILITIES. Support export and import permitting and licensing.
Cannabis Law Report
DECEMBER 15, 2021
Responsible for creation and maintenance of all regulatory documentation, including but not limited to, product packaging, labelling, inserts, working in conjunction with the marketing team for design, and assuring regulatory compliance across all territories. ROLE/RESPONSIBILITIES. Support export and import permitting and licensing.
Cannabis Law Report
OCTOBER 10, 2021
Cantourage is an innovative company ensuring that patients are able to access the newest medicinal products based on cannabis. Provide guidance on clinical trials and plays integral role in bringing new product innovations to different markets in Europe (and beyond). Customized compensation package.
Cannabis Law Report
NOVEMBER 19, 2021
It has been designated a Breakthrough Therapy by the FDA and the results of our pivotal Phase 3 clinical trial were published in Nature Medicine or profiled on the front page of The New York Times. MAPS PBC strives to establish a supportive, equitable and accessible work environment. Deputy General Counsel Executive Summary.
Expert insights. Personalized for you.
52 
Let's personalize your content